Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study.
Dong-Xu QiuJian LiJin-Wei ZhangMin-Feng ChenXiao-Mei GaoYong-Xiang TangYe ZhangXiao-Ping YiHong-Ling YinYu GanGui-Lin WangXiong-Bing ZuShuo HuYi CaiPublished in: European journal of nuclear medicine and molecular imaging (2021)
Dual-tracer PET/CT might screen patients for avoiding unnecessary biopsy. Dual-tracer PET/CT-TB plus SB might be a more effective and promising strategy for the definite diagnosis of clinically significant PCa than mpMRI-TB.
Keyphrases
- pet ct
- positron emission tomography
- prostate cancer
- ultrasound guided
- end stage renal disease
- fine needle aspiration
- pet imaging
- mycobacterium tuberculosis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- radical prostatectomy
- prognostic factors
- peritoneal dialysis
- computed tomography
- high throughput
- patient reported outcomes
- single cell
- patient reported